img

Global Biological Excipient Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biological Excipient Market Insights, Forecast to 2034

Biologic excipients are compounds excluding the pharmacologically active drug component that are used in the synthesis of biologic drugs or are found in the dosage form of a finished pharmaceutical product. They help with formulation design and have a variety of functions, including boosting flow ability, improving flow ability, and increasing compressibility. The biologic excipients market is developing due to rising demand for prolonged or sustained-release formulations and increasing demand for biologic excipients. During the projected period, growing regulatory stringency regarding medication and excipient approval is expected to restrain the market's growth. Patient safety is dependent on the quality of pharmaceutical excipients throughout their life cycle. Low-quality excipients' effects, such as decreased API solubility, have enhanced the necessity of managing many parts of the excipient life cycle, such as design, production and transportation.
Global Biological Excipient market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Biological Excipient industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Biological Excipient key manufacturers include Ashland Inc., BASF Corporation, Colorcon Inc., Evonik Industries, FMC Corporation, The Archer Daniels Midland Company, The Dow Chemical Company, Wacker Chemie AG. and Merck KGaA, etc. Ashland Inc., BASF Corporation, Colorcon Inc. are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Biological Excipient were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Biological Excipient market and estimated to attract more attentions from industry insiders and investors.
Biological Excipient can be divided into Oral and Topical, etc. Oral is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Biological Excipient is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Biological Excipient industry development. In 2022, global % sales of Biological Excipient went into Hospitals filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Biological Excipient market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Biological Excipient market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Ashland Inc.
BASF Corporation
Colorcon Inc.
Evonik Industries
FMC Corporation
The Archer Daniels Midland Company
The Dow Chemical Company
Wacker Chemie AG.
Merck KGaA
Colorcon
Associated British Foods plc
Signet Excipients Pvt. Ltd (IMCD)
Sigachi Industries Limited
Spectrum Chemical Manufacturing Corp.
IMCD
Clariant
Segment by Type
Oral
Topical

Segment by Application


Hospitals
Clinics
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Biological Excipient plant distribution, commercial date of Biological Excipient, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Biological Excipient introduction, etc. Biological Excipient Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Biological Excipient
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Biological Excipient Product Introduction
1.2 Market by Type
1.2.1 Global Biological Excipient Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Topical
1.3 Market by Application
1.3.1 Global Biological Excipient Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biological Excipient Sales Estimates and Forecasts 2018-2029
2.2 Global Biological Excipient Revenue by Region
2.2.1 Global Biological Excipient Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Biological Excipient Revenue by Region (2018-2024)
2.2.3 Global Biological Excipient Revenue by Region (2024-2029)
2.2.4 Global Biological Excipient Revenue Market Share by Region (2018-2029)
2.3 Global Biological Excipient Sales Estimates and Forecasts 2018-2029
2.4 Global Biological Excipient Sales by Region
2.4.1 Global Biological Excipient Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Biological Excipient Sales by Region (2018-2024)
2.4.3 Global Biological Excipient Sales by Region (2024-2029)
2.4.4 Global Biological Excipient Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Biological Excipient Sales by Manufacturers
3.1.1 Global Biological Excipient Sales by Manufacturers (2018-2024)
3.1.2 Global Biological Excipient Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biological Excipient in 2022
3.2 Global Biological Excipient Revenue by Manufacturers
3.2.1 Global Biological Excipient Revenue by Manufacturers (2018-2024)
3.2.2 Global Biological Excipient Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Biological Excipient Revenue in 2022
3.3 Global Key Players of Biological Excipient, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Biological Excipient Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Biological Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Biological Excipient, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Biological Excipient, Product Offered and Application
3.8 Global Key Manufacturers of Biological Excipient, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biological Excipient Sales by Type
4.1.1 Global Biological Excipient Historical Sales by Type (2018-2024)
4.1.2 Global Biological Excipient Forecasted Sales by Type (2024-2029)
4.1.3 Global Biological Excipient Sales Market Share by Type (2018-2029)
4.2 Global Biological Excipient Revenue by Type
4.2.1 Global Biological Excipient Historical Revenue by Type (2018-2024)
4.2.2 Global Biological Excipient Forecasted Revenue by Type (2024-2029)
4.2.3 Global Biological Excipient Revenue Market Share by Type (2018-2029)
4.3 Global Biological Excipient Price by Type
4.3.1 Global Biological Excipient Price by Type (2018-2024)
4.3.2 Global Biological Excipient Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Biological Excipient Sales by Application
5.1.1 Global Biological Excipient Historical Sales by Application (2018-2024)
5.1.2 Global Biological Excipient Forecasted Sales by Application (2024-2029)
5.1.3 Global Biological Excipient Sales Market Share by Application (2018-2029)
5.2 Global Biological Excipient Revenue by Application
5.2.1 Global Biological Excipient Historical Revenue by Application (2018-2024)
5.2.2 Global Biological Excipient Forecasted Revenue by Application (2024-2029)
5.2.3 Global Biological Excipient Revenue Market Share by Application (2018-2029)
5.3 Global Biological Excipient Price by Application
5.3.1 Global Biological Excipient Price by Application (2018-2024)
5.3.2 Global Biological Excipient Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Biological Excipient Market Size by Type
6.1.1 US & Canada Biological Excipient Sales by Type (2018-2029)
6.1.2 US & Canada Biological Excipient Revenue by Type (2018-2029)
6.2 US & Canada Biological Excipient Market Size by Application
6.2.1 US & Canada Biological Excipient Sales by Application (2018-2029)
6.2.2 US & Canada Biological Excipient Revenue by Application (2018-2029)
6.3 US & Canada Biological Excipient Market Size by Country
6.3.1 US & Canada Biological Excipient Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Biological Excipient Sales by Country (2018-2029)
6.3.3 US & Canada Biological Excipient Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Biological Excipient Market Size by Type
7.1.1 Europe Biological Excipient Sales by Type (2018-2029)
7.1.2 Europe Biological Excipient Revenue by Type (2018-2029)
7.2 Europe Biological Excipient Market Size by Application
7.2.1 Europe Biological Excipient Sales by Application (2018-2029)
7.2.2 Europe Biological Excipient Revenue by Application (2018-2029)
7.3 Europe Biological Excipient Market Size by Country
7.3.1 Europe Biological Excipient Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Biological Excipient Sales by Country (2018-2029)
7.3.3 Europe Biological Excipient Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Biological Excipient Market Size
8.1.1 China Biological Excipient Sales (2018-2029)
8.1.2 China Biological Excipient Revenue (2018-2029)
8.2 China Biological Excipient Market Size by Application
8.2.1 China Biological Excipient Sales by Application (2018-2029)
8.2.2 China Biological Excipient Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biological Excipient Market Size by Type
9.1.1 Asia Biological Excipient Sales by Type (2018-2029)
9.1.2 Asia Biological Excipient Revenue by Type (2018-2029)
9.2 Asia Biological Excipient Market Size by Application
9.2.1 Asia Biological Excipient Sales by Application (2018-2029)
9.2.2 Asia Biological Excipient Revenue by Application (2018-2029)
9.3 Asia Biological Excipient Sales by Region
9.3.1 Asia Biological Excipient Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Biological Excipient Revenue by Region (2018-2029)
9.3.3 Asia Biological Excipient Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Biological Excipient Market Size by Type
10.1.1 Middle East, Africa and Latin America Biological Excipient Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Biological Excipient Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Biological Excipient Market Size by Application
10.2.1 Middle East, Africa and Latin America Biological Excipient Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Biological Excipient Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Biological Excipient Sales by Country
10.3.1 Middle East, Africa and Latin America Biological Excipient Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Biological Excipient Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Biological Excipient Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Ashland Inc.
11.1.1 Ashland Inc. Company Information
11.1.2 Ashland Inc. Overview
11.1.3 Ashland Inc. Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Ashland Inc. Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Ashland Inc. Recent Developments
11.2 BASF Corporation
11.2.1 BASF Corporation Company Information
11.2.2 BASF Corporation Overview
11.2.3 BASF Corporation Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 BASF Corporation Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BASF Corporation Recent Developments
11.3 Colorcon Inc.
11.3.1 Colorcon Inc. Company Information
11.3.2 Colorcon Inc. Overview
11.3.3 Colorcon Inc. Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Colorcon Inc. Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Colorcon Inc. Recent Developments
11.4 Evonik Industries
11.4.1 Evonik Industries Company Information
11.4.2 Evonik Industries Overview
11.4.3 Evonik Industries Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Evonik Industries Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Evonik Industries Recent Developments
11.5 FMC Corporation
11.5.1 FMC Corporation Company Information
11.5.2 FMC Corporation Overview
11.5.3 FMC Corporation Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 FMC Corporation Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 FMC Corporation Recent Developments
11.6 The Archer Daniels Midland Company
11.6.1 The Archer Daniels Midland Company Company Information
11.6.2 The Archer Daniels Midland Company Overview
11.6.3 The Archer Daniels Midland Company Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 The Archer Daniels Midland Company Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 The Archer Daniels Midland Company Recent Developments
11.7 The Dow Chemical Company
11.7.1 The Dow Chemical Company Company Information
11.7.2 The Dow Chemical Company Overview
11.7.3 The Dow Chemical Company Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 The Dow Chemical Company Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 The Dow Chemical Company Recent Developments
11.8 Wacker Chemie AG.
11.8.1 Wacker Chemie AG. Company Information
11.8.2 Wacker Chemie AG. Overview
11.8.3 Wacker Chemie AG. Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Wacker Chemie AG. Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wacker Chemie AG. Recent Developments
11.9 Merck KGaA
11.9.1 Merck KGaA Company Information
11.9.2 Merck KGaA Overview
11.9.3 Merck KGaA Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Merck KGaA Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck KGaA Recent Developments
11.10 Colorcon
11.10.1 Colorcon Company Information
11.10.2 Colorcon Overview
11.10.3 Colorcon Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Colorcon Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Colorcon Recent Developments
11.11 Associated British Foods plc
11.11.1 Associated British Foods plc Company Information
11.11.2 Associated British Foods plc Overview
11.11.3 Associated British Foods plc Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Associated British Foods plc Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Associated British Foods plc Recent Developments
11.12 Signet Excipients Pvt. Ltd (IMCD)
11.12.1 Signet Excipients Pvt. Ltd (IMCD) Company Information
11.12.2 Signet Excipients Pvt. Ltd (IMCD) Overview
11.12.3 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Signet Excipients Pvt. Ltd (IMCD) Recent Developments
11.13 Sigachi Industries Limited
11.13.1 Sigachi Industries Limited Company Information
11.13.2 Sigachi Industries Limited Overview
11.13.3 Sigachi Industries Limited Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Sigachi Industries Limited Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Sigachi Industries Limited Recent Developments
11.14 Spectrum Chemical Manufacturing Corp.
11.14.1 Spectrum Chemical Manufacturing Corp. Company Information
11.14.2 Spectrum Chemical Manufacturing Corp. Overview
11.14.3 Spectrum Chemical Manufacturing Corp. Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Spectrum Chemical Manufacturing Corp. Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Spectrum Chemical Manufacturing Corp. Recent Developments
11.15 IMCD
11.15.1 IMCD Company Information
11.15.2 IMCD Overview
11.15.3 IMCD Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 IMCD Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 IMCD Recent Developments
11.16 Clariant
11.16.1 Clariant Company Information
11.16.2 Clariant Overview
11.16.3 Clariant Biological Excipient Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Clariant Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Clariant Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biological Excipient Industry Chain Analysis
12.2 Biological Excipient Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biological Excipient Production Mode & Process
12.4 Biological Excipient Sales and Marketing
12.4.1 Biological Excipient Sales Channels
12.4.2 Biological Excipient Distributors
12.5 Biological Excipient Customers
13 Market Dynamics
13.1 Biological Excipient Industry Trends
13.2 Biological Excipient Market Drivers
13.3 Biological Excipient Market Challenges
13.4 Biological Excipient Market Restraints
14 Key Findings in The Global Biological Excipient Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Biological Excipient Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Oral
Table 3. Major Manufacturers of Topical
Table 4. Global Biological Excipient Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Biological Excipient Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Biological Excipient Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Biological Excipient Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Biological Excipient Revenue Market Share by Region (2018-2024)
Table 9. Global Biological Excipient Revenue Market Share by Region (2024-2029)
Table 10. Global Biological Excipient Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Biological Excipient Sales by Region (2018-2024) & (K Units)
Table 12. Global Biological Excipient Sales by Region (2024-2029) & (K Units)
Table 13. Global Biological Excipient Sales Market Share by Region (2018-2024)
Table 14. Global Biological Excipient Sales Market Share by Region (2024-2029)
Table 15. Global Biological Excipient Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Biological Excipient Sales Share by Manufacturers (2018-2024)
Table 17. Global Biological Excipient Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Biological Excipient Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Biological Excipient, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Biological Excipient Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Biological Excipient Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Biological Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Excipient as of 2022)
Table 23. Global Key Manufacturers of Biological Excipient, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Biological Excipient, Product Offered and Application
Table 25. Global Key Manufacturers of Biological Excipient, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Biological Excipient Sales by Type (2018-2024) & (K Units)
Table 28. Global Biological Excipient Sales by Type (2024-2029) & (K Units)
Table 29. Global Biological Excipient Sales Share by Type (2018-2024)
Table 30. Global Biological Excipient Sales Share by Type (2024-2029)
Table 31. Global Biological Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Biological Excipient Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Biological Excipient Revenue Share by Type (2018-2024)
Table 34. Global Biological Excipient Revenue Share by Type (2024-2029)
Table 35. Biological Excipient Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Biological Excipient Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Biological Excipient Sales by Application (2018-2024) & (K Units)
Table 38. Global Biological Excipient Sales by Application (2024-2029) & (K Units)
Table 39. Global Biological Excipient Sales Share by Application (2018-2024)
Table 40. Global Biological Excipient Sales Share by Application (2024-2029)
Table 41. Global Biological Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Biological Excipient Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Biological Excipient Revenue Share by Application (2018-2024)
Table 44. Global Biological Excipient Revenue Share by Application (2024-2029)
Table 45. Biological Excipient Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Biological Excipient Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Biological Excipient Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Biological Excipient Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Biological Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Biological Excipient Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Biological Excipient Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Biological Excipient Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Biological Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Biological Excipient Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Biological Excipient Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Biological Excipient Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Biological Excipient Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Biological Excipient Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Biological Excipient Sales by Country (2024-2029) & (K Units)
Table 60. Europe Biological Excipient Sales by Type (2018-2024) & (K Units)
Table 61. Europe Biological Excipient Sales by Type (2024-2029) & (K Units)
Table 62. Europe Biological Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Biological Excipient Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Biological Excipient Sales by Application (2018-2024) & (K Units)
Table 65. Europe Biological Excipient Sales by Application (2024-2029) & (K Units)
Table 66. Europe Biological Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Biological Excipient Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Biological Excipient Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Biological Excipient Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Biological Excipient Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Biological Excipient Sales by Country (2018-2024) & (K Units)
Table 72. Europe Biological Excipient Sales by Country (2024-2029) & (K Units)
Table 73. China Biological Excipient Sales by Type (2018-2024) & (K Units)
Table 74. China Biological Excipient Sales by Type (2024-2029) & (K Units)
Table 75. China Biological Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Biological Excipient Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Biological Excipient Sales by Application (2018-2024) & (K Units)
Table 78. China Biological Excipient Sales by Application (2024-2029) & (K Units)
Table 79. China Biological Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Biological Excipient Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Biological Excipient Sales by Type (2018-2024) & (K Units)
Table 82. Asia Biological Excipient Sales by Type (2024-2029) & (K Units)
Table 83. Asia Biological Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Biological Excipient Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Biological Excipient Sales by Application (2018-2024) & (K Units)
Table 86. Asia Biological Excipient Sales by Application (2024-2029) & (K Units)
Table 87. Asia Biological Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Biological Excipient Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Biological Excipient Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Biological Excipient Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Biological Excipient Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Biological Excipient Sales by Region (2018-2024) & (K Units)
Table 93. Asia Biological Excipient Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Biological Excipient Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Biological Excipient Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Biological Excipient Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Biological Excipient Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Biological Excipient Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Biological Excipient Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Biological Excipient Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Biological Excipient Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Biological Excipient Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Biological Excipient Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Biological Excipient Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Biological Excipient Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Biological Excipient Sales by Country (2024-2029) & (K Units)
Table 107. Ashland Inc. Company Information
Table 108. Ashland Inc. Description and Major Businesses
Table 109. Ashland Inc. Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Ashland Inc. Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Ashland Inc. Recent Developments
Table 112. BASF Corporation Company Information
Table 113. BASF Corporation Description and Major Businesses
Table 114. BASF Corporation Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. BASF Corporation Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. BASF Corporation Recent Developments
Table 117. Colorcon Inc. Company Information
Table 118. Colorcon Inc. Description and Major Businesses
Table 119. Colorcon Inc. Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Colorcon Inc. Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Colorcon Inc. Recent Developments
Table 122. Evonik Industries Company Information
Table 123. Evonik Industries Description and Major Businesses
Table 124. Evonik Industries Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Evonik Industries Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Evonik Industries Recent Developments
Table 127. FMC Corporation Company Information
Table 128. FMC Corporation Description and Major Businesses
Table 129. FMC Corporation Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. FMC Corporation Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. FMC Corporation Recent Developments
Table 132. The Archer Daniels Midland Company Company Information
Table 133. The Archer Daniels Midland Company Description and Major Businesses
Table 134. The Archer Daniels Midland Company Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. The Archer Daniels Midland Company Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. The Archer Daniels Midland Company Recent Developments
Table 137. The Dow Chemical Company Company Information
Table 138. The Dow Chemical Company Description and Major Businesses
Table 139. The Dow Chemical Company Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. The Dow Chemical Company Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. The Dow Chemical Company Recent Developments
Table 142. Wacker Chemie AG. Company Information
Table 143. Wacker Chemie AG. Description and Major Businesses
Table 144. Wacker Chemie AG. Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Wacker Chemie AG. Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Wacker Chemie AG. Recent Developments
Table 147. Merck KGaA Company Information
Table 148. Merck KGaA Description and Major Businesses
Table 149. Merck KGaA Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Merck KGaA Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Merck KGaA Recent Developments
Table 152. Colorcon Company Information
Table 153. Colorcon Description and Major Businesses
Table 154. Colorcon Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Colorcon Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Colorcon Recent Developments
Table 157. Associated British Foods plc Company Information
Table 158. Associated British Foods plc Description and Major Businesses
Table 159. Associated British Foods plc Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Associated British Foods plc Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Associated British Foods plc Recent Developments
Table 162. Signet Excipients Pvt. Ltd (IMCD) Company Information
Table 163. Signet Excipients Pvt. Ltd (IMCD) Description and Major Businesses
Table 164. Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Signet Excipients Pvt. Ltd (IMCD) Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Signet Excipients Pvt. Ltd (IMCD) Recent Developments
Table 167. Sigachi Industries Limited Company Information
Table 168. Sigachi Industries Limited Description and Major Businesses
Table 169. Sigachi Industries Limited Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Sigachi Industries Limited Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Sigachi Industries Limited Recent Developments
Table 172. Spectrum Chemical Manufacturing Corp. Company Information
Table 173. Spectrum Chemical Manufacturing Corp. Description and Major Businesses
Table 174. Spectrum Chemical Manufacturing Corp. Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Spectrum Chemical Manufacturing Corp. Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Spectrum Chemical Manufacturing Corp. Recent Developments
Table 177. IMCD Company Information
Table 178. IMCD Description and Major Businesses
Table 179. IMCD Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. IMCD Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. IMCD Recent Developments
Table 182. Clariant Company Information
Table 183. Clariant Description and Major Businesses
Table 184. Clariant Biological Excipient Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. Clariant Biological Excipient Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Clariant Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Biological Excipient Distributors List
Table 190. Biological Excipient Customers List
Table 191. Biological Excipient Market Trends
Table 192. Biological Excipient Market Drivers
Table 193. Biological Excipient Market Challenges
Table 194. Biological Excipient Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Biological Excipient Product Picture
Figure 2. Global Biological Excipient Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Biological Excipient Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Topical Product Picture
Figure 6. Global Biological Excipient Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Biological Excipient Market Share by Application in 2022 & 2029
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Biological Excipient Report Years Considered
Figure 12. Global Biological Excipient Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Biological Excipient Revenue 2018-2029 (US$ Million)
Figure 14. Global Biological Excipient Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Biological Excipient Revenue Market Share by Region (2018-2029)
Figure 16. Global Biological Excipient Sales 2018-2029 ((K Units)
Figure 17. Global Biological Excipient Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Biological Excipient Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Biological Excipient Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Biological Excipient Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Biological Excipient Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Biological Excipient Sales YoY (2018-2029) & (K Units)
Figure 23. China Biological Excipient Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Biological Excipient Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Biological Excipient Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Biological Excipient Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Biological Excipient Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Biological Excipient Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Biological Excipient in the World: Market Share by Biological Excipient Revenue in 2022
Figure 30. Global Biological Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Biological Excipient Sales Market Share by Type (2018-2029)
Figure 32. Global Biological Excipient Revenue Market Share by Type (2018-2029)
Figure 33. Global Biological Excipient Sales Market Share by Application (2018-2029)
Figure 34. Global Biological Excipient Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Biological Excipient Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Biological Excipient Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Biological Excipient Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Biological Excipient Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Biological Excipient Revenue Share by Country (2018-2029)
Figure 40. US & Canada Biological Excipient Sales Share by Country (2018-2029)
Figure 41. U.S. Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Biological Excipient Sales Market Share by Type (2018-2029)
Figure 44. Europe Biological Excipient Revenue Market Share by Type (2018-2029)
Figure 45. Europe Biological Excipient Sales Market Share by Application (2018-2029)
Figure 46. Europe Biological Excipient Revenue Market Share by Application (2018-2029)
Figure 47. Europe Biological Excipient Revenue Share by Country (2018-2029)
Figure 48. Europe Biological Excipient Sales Share by Country (2018-2029)
Figure 49. Germany Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 50. France Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 54. China Biological Excipient Sales Market Share by Type (2018-2029)
Figure 55. China Biological Excipient Revenue Market Share by Type (2018-2029)
Figure 56. China Biological Excipient Sales Market Share by Application (2018-2029)
Figure 57. China Biological Excipient Revenue Market Share by Application (2018-2029)
Figure 58. Asia Biological Excipient Sales Market Share by Type (2018-2029)
Figure 59. Asia Biological Excipient Revenue Market Share by Type (2018-2029)
Figure 60. Asia Biological Excipient Sales Market Share by Application (2018-2029)
Figure 61. Asia Biological Excipient Revenue Market Share by Application (2018-2029)
Figure 62. Asia Biological Excipient Revenue Share by Region (2018-2029)
Figure 63. Asia Biological Excipient Sales Share by Region (2018-2029)
Figure 64. Japan Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 68. India Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Biological Excipient Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Biological Excipient Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Biological Excipient Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Biological Excipient Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Biological Excipient Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Biological Excipient Sales Share by Country (2018-2029)
Figure 75. Brazil Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Biological Excipient Revenue (2018-2029) & (US$ Million)
Figure 80. Biological Excipient Value Chain
Figure 81. Biological Excipient Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed